0001193125-23-199907 Sample Contracts
FORM OF COMPANY STOCKHOLDER VOTING AGREEMENTVoting Agreement • August 1st, 2023 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 1st, 2023 Company Industry JurisdictionThis Voting Agreement (this “Agreement”) is made and entered into as of July 31, 2023 (the “Agreement Date”), by and among Revolution Medicines, Inc., a Delaware corporation (“Parent”), and the undersigned, a stockholder of EQRx, Inc., a Delaware corporation (the “Company”, and such stockholder, the “Stockholder”). Parent and the Stockholder are each individually sometimes referred to herein as a “Party”.
FORM OF STOCKHOLDER LOCK-UP AGREEMENT July 31, 2023Stockholder Lock-Up Agreement • August 1st, 2023 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 1st, 2023 Company Industry
AGREEMENT AND PLAN OF MERGER among REVOLUTION MEDICINES, INC., a Delaware corporation, EQRX, INC., a Delaware corporation, EQUINOX MERGER SUB I, INC., a Delaware corporation and EQUINOX MERGER SUB II LLC, a Delaware limited liability company Dated as...Merger Agreement • August 1st, 2023 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 1st, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of July 31, 2023, by and among REVOLUTION MEDICINES, INC., a Delaware corporation (“Parent”), EQRX, INC., a Delaware corporation (the “Company”), EQUINOX MERGER SUB I, INC., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub I”), and EQUINOX MERGER SUB II LLC, a Delaware limited liability company and wholly owned Subsidiary of Parent (“Merger Sub II” and, together with Merger Sub I, the “Merger Subs” and each a “Merger Sub”). Parent, the Company and the Merger Subs are each sometimes referred to herein as a “Party” and, collectively, as the “Parties.” Certain capitalized terms used in this Agreement are defined in Exhibit A.